ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627745 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627745; 2) Community: the network communities that were significantly associated with the response to NSC 627745; 3) Molecule: the relationships between components within communities and NSC 627745; 4) MDR: the compounds that were significantly associated with the NSC 627745.

NSC Compound Enrichment Correlation
NSC 734982 Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate 0.0490935610249068 -0.26381956
NSC 681641 Camptothecin Derivative 0.049093561024907 0.26926844
NSC 683556 Camptothecin Derivative 0.049093561024907 0.16452678
NSC 685886 Null 0.049093561024907 -0.13347031
NSC 720336 Null 0.049093561024907 -0.0021294426
NSC 342610 Null 0.0490935610249072 0.33266199
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0490935610249072 0.72970603
NSC 713320 Null 1.2187791866317e-005 0.70076811
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 1.49667137663233e-005 0.79640561
NSC 732698 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne 1.49667137663233e-005 0.46182254
Total:131  Current:129    [First] [Prev] [Next] [Last]